A Phase I study of adjuvant chemotherapy with gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Adverse reactions
- 05 Oct 2017 Status changed from active, no longer recruiting to completed.
- 31 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Oct 2012 Planned end date (Mar 2017) added as reported by ClinicalTrials.gov.